
Number of patents granted for the top selling U.S. drugs 2022
As of August 2022, 165 patents have been granted for the world's top drug Humira in the United States, compared to 117 patents issued for the drug Revlimid. This statistic illustrates the number of patents issued for top selling drugs in the United States.